Co-Authors
This is a "connection" page, showing publications co-authored by Changgui Li and Shufang Meng.
Connection Strength
0.118
-
COVID-19 vaccines: progress and understanding on quality control and evaluation. Signal Transduct Target Ther. 2021 05 18; 6(1):199.
Score: 0.059
-
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 08; 21(8):1107-1119.
Score: 0.059